UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report

Indian journal of pathology & microbiology, 2021-01, Vol.64 (1), p.149-151

2021

Volltextzugriff (PDF)

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Annals of hematology, 2023-01, Vol.102 (1), p.133-140

2023

Volltextzugriff (PDF)

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Journal of chemotherapy (Florence), 2022-04, Vol.34 (3), p.190-198

2022

Volltextzugriff (PDF)

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

Turkish journal of haematology, 2022-08, Vol.39 (3), p.206-210

2022

Volltextzugriff (PDF)

Sequencing novel agents in the treatment of classical Hodgkin lymphoma

Expert review of hematology, 2023-12, Vol.16 (12), p.991-1015

2023

Volltextzugriff (PDF)

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Turkish journal of haematology, 2022-12, Vol.39 (4), p.254-261

2022

Volltextzugriff (PDF)

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis

Leukemia & lymphoma, 2016-05, Vol.57 (5), p.1211-1214

2016

Volltextzugriff (PDF)

Diagnostic contribution of 18F-FDG-PET/CT in fever of unknown origin

International journal of infectious diseases, 2014-02, Vol.19, p.53-58

2014

Volltextzugriff (PDF)

Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2018-05, Vol.378 (22), p.2141

2018

Volltextzugriff (PDF)

Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates

Transfusion and apheresis science, 2016-02, Vol.54 (1), p.53-59

2016

Volltextzugriff (PDF)

IRF4 -Rearranged Large B-Cell Lymphoma on Waldeyer’s Ring: A Case Report

Turkish journal of haematology, 2020-11, Vol.37 (4), p.292-294

2020

Volltextzugriff (PDF)

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

Hematology, Transfusion and Cell Therapy, 2021-11, Vol.43, p.S4-S4

2021

Volltextzugriff (PDF)

Intravascular Large B-Cell Lymphoma Within the Appendix Presenting as Acute Abdomen: A Challenging Diagnosis for Hematologists

Turkish journal of haematology, 2021-02, Vol.38 (1), p.89-91

2021

Volltextzugriff (PDF)

A Case of Burkitt’s Lymphoma Mimicking Peritonitis Carcinomatosa

Turkish journal of haematology, 2020-01, Vol.37 (3), p.215-216

2020

Volltextzugriff (PDF)

Primary Gastrointestinal Diffuse Large B Cell Lymphoma Presenting with Cold Agglutinin Disease

Case reports in gastroenterology, 2011-05, Vol.5 (2), p.262-266

2011

Volltextzugriff (PDF)

Long Term Follow-up of International Randomised Phase 3 Study of Rituximab Versus a Watch and Wait Approach for Patients with Asymptomatic, Low Tumour Burden Follicular Lymphoma Shows Rituximab Is Highly Effective at Delaying Time to New Treatment without Detrimental Impact Following Next Line of Therapy

Blood, 2022-11, Vol.140 (Supplement 1), p.1456-1458

2022

Volltextzugriff (PDF)

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Blood, 2022-11, Vol.140 (Supplement 1), p.6704-6705

2022

Volltextzugriff (PDF)

Treatment of Mantle-Cell Lymphoma

The New England journal of medicine, 2022-09, Vol.387 (12), p.1146-1148

2022

Volltextzugriff (PDF)

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Turkish journal of haematology, 2012-09, Vol.29 (3), p.242-247

2012

Volltextzugriff (PDF)

Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data

Blood, 2020-11, Vol.136 (Supplement 1), p.14-15

2020

Volltextzugriff (PDF)

Venetoclax–Rituximab in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2018-05, Vol.378 (22), p.2141-2144

2018

Volltextzugriff (PDF)

R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.4585-4585

2021

Volltextzugriff (PDF)

Use of Positron Emission Tomography in Patients with Classical Hodgkin Lymphoma Outside of Europe and North America: Results from the International, Multi-Center, Retrospective B-Holistic Study

Blood, 2021-11, Vol.138 (Supplement 1), p.1397-1397

2021

Volltextzugriff (PDF)

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.32-34

2020

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(90)
Berichte
(7)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Hematology
(22)
Humans
(20)
Oncology
(14)
Lymphoma
(10)
Male
(10)
Adult
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Biological And Medical Sciences
(6)
Case Report
(5)
Hodgkin Lymphoma
(5)
Medical Sciences
(5)
Rituximab
(5)
Brentuximab Vedotin
(4)
Patients
(4)
Risk Factors
(4)
Stem Cell Transplantation
(4)
Case Reports
(3)
Fatal Outcome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Concomittant occurence of well-differentiated thyroid carcinoma metastasis and chronic lymphocytic leukemia in the same lymph node along with internal jugular vein thrombus: a case report

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

Sequencing novel agents in the treatment of classical Hodgkin lymphoma

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis

Diagnostic contribution of 18F-FDG-PET/CT in fever of unknown origin

Venetoclax-Rituximab in Chronic Lymphocytic Leukemia

Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates

IRF4 -Rearranged Large B-Cell Lymphoma on Waldeyer’s Ring: A Case Report

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

Intravascular Large B-Cell Lymphoma Within the Appendix Presenting as Acute Abdomen: A Challenging Diagnosis for Hematologists

A Case of Burkitt’s Lymphoma Mimicking Peritonitis Carcinomatosa

Primary Gastrointestinal Diffuse Large B Cell Lymphoma Presenting with Cold Agglutinin Disease

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Treatment of Mantle-Cell Lymphoma

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenström Macroglobulinemia: A Real World Data

Venetoclax–Rituximab in Chronic Lymphocytic Leukemia

R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Use of Positron Emission Tomography in Patients with Classical Hodgkin Lymphoma Outside of Europe and North America: Results from the International, Multi-Center, Retrospective B-Holistic Study

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Aktive Filter

Suchergebnisse filtern